In conclusion, we demonstrated that CDDO-Im alleviates sepsis-related ARDS through the activation of PINK1/Parkin-mediated mitophagy to inhibit AM pyroptosis and HMGB1 release bothin vivo andin vitro via the Nrf2 pathway. Here, PRKN is linked to Sepsis.